Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction

Annals of Pharmacotherapy

Volumn 32, Issue 7-8, 1998, Pages 761-765

  Michalets, E L ^a   Smith, L K ^a   Van Tassel, E D ^a  

^a Mission St Joseph's Health System   (United States)

Author keywords

Cyclobenzaprine; Droperidol; Fluoxetine; Torsade de pointes

Indexed keywords

AMLODIPINE; ATRACURIUM; BUPIVACAINE; CEFAZOLIN; CYCLOBENZAPRINE; CYTOCHROME P450; CYTOCHROME P450 INHIBITOR; DICLOFENAC; DROPERIDOL; FENTANYL; FLUOXETINE; KETOROLAC; LIDOCAINE; METOCLOPRAMIDE; MIDAZOLAM; NITROUS OXIDE; PROPOFOL; TRIAMTERENE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PATIENT MONITORING; PREMEDICATION; PRIORITY JOURNAL; QT INTERVAL; TORSADE DES POINTES;

EID: 0031827893     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.17351     Document Type: Article

References (26)